Frontier IP Group plc Second Portuguese spin out: Des Solutio
30 October 2018 - 6:00PM
RNS Non-Regulatory
TIDMFIPP
Frontier IP Group plc
30 October 2018
30 October 2018
Frontier IP Group Plc
("Frontier IP" or the "Group")
Portfolio news - Second Portuguese spin out Des Solutio to
develop green chemistry for beauty, pharmaceutical and food
industries
Frontier IP, a specialist in commercialising university
intellectual property, today announces it is taking a 25 per cent.
stake in Des Solutio (the "Company"), a company developing safer
and greener alternatives to the chemicals currently used to make
beauty, pharmaceutical, personal care and other products.
The Company has been established to develop and commercialise
the research of Associate Professor Ana Rita Duarte and Dr
Alexandre Paiva, of Portugal's NOVA University Lisbon, NOVA School
of Science and Technology ("FCT NOVA").
Their research has already attracted interest from several major
industrial groups, including a world-leading cosmetics company and
a major pharmaceutical company. In return for its stake, Frontier
IP will provide Des Solutio with a broad range of commercialisation
services, including contract negotiation and identifying and
working with potential industry partners to validate and scale up
the technology.
Des Solutio is developing new methods to use Natural Deep
Eutectic Solvents ("NADES") in cosmetics, nutraceuticals and other
applications, to replace toxic organic solvents, such as ethanol,
employed currently. Solvents are commonly used in a wide range of
industries to extract active ingredients from natural matrices,
such as olive oil, mint or seaweed to flavour and scent their
products, and enhance the shelf-life and stability of the
bioactives.
NADES offer many benefits over existing solvents. Found in a
vast range of plants, and so compliant with a green chemistry
philosophy, they are entirely derived from natural compounds such
as organic acids, amino acids and sugars.
As there are a vast range of NADES already identified, they can
be matched to specific active ingredients to extract only what is
needed. There is no need to recover an active ingredient from a
NADES, unlike conventional solvents, some of which are too toxic
for use on skin or in foods.
Other advantages of the technology include improved solubility,
permeability and bioavailability of the active compounds, better
biodegradability than many organic solvents and greener production
processes.
The incorporation of Des Solutio is a further sign of Frontier
IP's growing momentum in Portugal. It is the Group's second spin
out from FCT NOVA following NTPE, a company developing novel
technology to print electronic circuits, sensors and semiconductors
on to paper. The Group recently entered into a strategic
partnership with the UK government's Department for International
Trade in Portugal.
Des Solutio co-founder, Associate Professor Ana Rita Duarte
said: "We're delighted to be working with Frontier IP on developing
and bringing this ground-breaking science into the commercial
world. NADES have huge potential for making a host of everyday
products greener and saferfor people to use."
Frontier IP chief executive Neil Crabb said: "We're very excited
about the possibilities for Des Solutio. The technology being
developed by Professor Ana Rita Duarte and Dr Alexandre Paiva has
already attracted interest from major multinationals. Its
incorporation as our second Portuguese spin out is further sign of
our growing strength in the country."
ENQUIRIES
Frontier IP Group Plc T: 0131 240 1251
Neil Crabb, Chief Executive
Andrew Johnson, Communications & Investor M: 07464 546 025
Relations
Company website: www.frontierip.co.uk
Allenby Capital Limited (Nominated Adviser T: 0203 328 5656
and Broker)
Nick Athanas / Nicholas Chambers (Corporate
Finance)
Amrit Nahal (Equity Sales)
NOTES TO EDITORS
Frontier IP unites science and commerce by identifying strong
intellectual property and accelerating its development through a
range of commercialisation services.
The Group looks to build and grow a portfolio of equity stakes
and licence income by taking an active involvement in spin-out
companies, including support for fund raising and collaboration
with relevant industry partners at an early stage of
development.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NRABLBDGBGDBGIC
(END) Dow Jones Newswires
October 30, 2018 03:00 ET (07:00 GMT)
Frontier Ip (LSE:FIPP)
Historical Stock Chart
From Jan 2025 to Feb 2025
Frontier Ip (LSE:FIPP)
Historical Stock Chart
From Feb 2024 to Feb 2025